Table II.
QM/Δ-MLP or MLP | DFTB | NDDO | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
ωB97X | QDπ | AIQM1 | ANI-2x | GFN2 | DFTB3 | ChIMES | ODM2 | D3H4X | PM7 | |
Complex | ΔE | Err | Err | Err | Err | Err | Err | Err | Err | Err |
‒32.90 | 0.16 | 7.75 | 9.84 | 3.66 | 10.98 | 0.08 | 10.35 | 4.87 | 1.92 | |
‒18.22 | ‒0.14 | 6.71 | 3.65 | 2.15 | 9.33 | 2.19 | 7.51 | 2.90 | 0.88 | |
‒18.36 | 0.17 | 7.39 | 3.39 | 2.12 | 9.35 | 2.22 | 7.45 | 2.94 | 0.96 | |
‒37.40 | 0.03 | 10.01 | 7.67 | 3.99 | 11.34 | ‒0.64 | 10.18 | 6.62 | 3.80 | |
‒34.52 | ‒0.00 | 9.70 | 8.04 | 2.43 | 9.32 | ‒2.73 | 8.57 | 5.25 | 1.83 | |
‒22.46 | ‒0.08 | 7.06 | 6.34 | 2.13 | 9.56 | 1.99 | 9.14 | 1.69 | ‒1.24 | |
‒33.11 | ‒0.05 | 8.13 | 10.77 | 3.65 | 10.14 | ‒0.76 | 10.93 | 5.50 | 1.83 | |
‒32.50 | ‒0.31 | 8.20 | 8.38 | 3.72 | 10.21 | ‒0.69 | 10.13 | 5.28 | 1.28 | |
‒33.68 | 0.13 | 7.45 | 10.02 | 4.56 | 11.02 | ‒0.56 | 11.61 | 6.47 | 1.77 | |
‒22.46 | 0.09 | 8.76 | 9.08 | 3.56 | 10.54 | 3.50 | 9.95 | 4.24 | ‒0.24 | |
‒33.99 | 0.03 | 7.28 | 10.79 | 4.59 | 10.11 | ‒3.34 | 9.56 | 5.51 | 3.22 | |
‒23.00 | 0.39 | 7.82 | 7.14 | 3.03 | 9.49 | ‒0.04 | 8.55 | 0.41 | ‒0.67 | |
‒25.59 | ‒0.11 | 8.99 | 13.00 | 3.14 | 10.75 | ‒2.45 | 8.60 | 1.71 | ‒3.49 | |
‒22.92 | ‒0.03 | 5.80 | 6.18 | 3.04 | 9.44 | 0.24 | 8.88 | 0.43 | ‒0.08 | |
‒144.48 | 0.10 | 12.53 | 79.73 | 14.30 | 18.59 | 8.26 | 15.79 | 15.52 | 15.29 | |
‒43.33 | ‒0.07 | 12.36 | 11.58 | 6.69 | 15.35 | 3.42 | 12.16 | 4.25 | 1.90 | |
‒47.17 | 0.04 | 6.77 | 24.45 | 3.38 | 13.41 | 0.87 | 9.41 | 7.35 | 4.82 | |
maE | … | 0.11 | 8.46 | 14.17 | 4.25 | 11.22 | 1.99 | 10.08 | 4.87 | 2.77 |
rmsE | … | 0.15 | 8.66 | 22.51 | 5.09 | 11.49 | 2.83 | 10.26 | 5.97 | 4.44 |
Models and datasets are described in Sec. II. An illustration of each of the complexes is provided in Fig. 4. Complexes include adenine (A), cytosine (C), guanine (G), thymine (T), uracil (U), isoguanine (B), isocytosine (S), 6-amino-5-nitropyridin-2-one (Z), 2-aminoimidazo[1,2a][1,3,5]triazin-4(1H)-one (P), imidazo[1,2-a]-1,3,5-triazine-2(8H)-4(3H)-dione (X), 2,4-diaminopyrimidine (K), 4-aminoimidazo[1,2-a][1,3,5]triazin-2(8H)-one (J), and 6-amino-3-methylpyridin-2(1H)-one (V).86,142 The “*” symbol refers to tautomeric form, and the “+” and “−” symbols refer to the positive and negative charge.